Development of evaluation system for bioactive substances using human artificial chromosome-mediated osteocalcin gene expression.
Takahashi
Yusuke
Y
Department of Molecular Biology, School of Life Sciences, Faculty of Medicine, Tottori University, Nishi-cho, Yonago 683-8503, Japan.
Tsuji
Saori
S
Kazuki
Yasuhiro
Y
Noguchi
Makoto
M
Arifuku
Ichiro
I
Umebayashi
Yukihiro
Y
Nakanishi
Tomoko
T
Oshimura
Mitsuo
M
Sato
Kenzo
K
D000818:Animals; D001681:Biological Assay / Q000379:methods*; D001685:Biological Factors / Q000032:analysis* / Q000494:pharmacology; D016466:CHO Cells; D002762:Cholecalciferol / Q000494:pharmacology; D022222:Chromosomes, Artificial, Human / Q000235:genetics*; D006224:Cricetinae; D003412:Cricetulus; D005395:Fish Oils / Q000737:chemistry; D005786:Gene Expression Regulation / Q000187:drug effects; D017930:Genes, Reporter / Q000235:genetics; D005822:Genetic Vectors / Q000235:genetics; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D019426:Integrases / Q000378:metabolism; D015675:Osteocalcin / Q000235:genetics*; D010012:Osteogenesis / Q000187:drug effects / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics; D011995:Recombination, Genetic / Q000187:drug effects / Q000235:genetics
D001685:Biological Factors; D005395:Fish Oils; D015675:Osteocalcin; D049452:Green Fluorescent Proteins; D002762:Cholecalciferol; C045073:Cre recombinase; D019426:Integrases